Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Jarero-Basulto, José J; Rivera-Cervantes, Martha C; Gasca-Martínez, Deisy; García-Sierra, Francisco; Gasca-Martínez, Yadira; Beas-Zárate, Carlos

Jarero-Basulto, José J; Rivera-Cervantes, Martha C; Gasca-Martínez, Deisy; García-Sierra, Francisco; Gasca-Martínez, Yadira; Beas-Zárate, Carlos.

Afiliação

Jarero-Basulto JJ; Cellular Neurobiology Laboratory, Cell and Molecular Biology Department, CUCBA, University of Guadalajara, Zapopan 45220, Mexico.
Rivera-Cervantes MC; Cellular Neurobiology Laboratory, Cell and Molecular Biology Department, CUCBA, University of Guadalajara, Zapopan 45220, Mexico.
Gasca-Martínez D; Behavioral Analysis Unit, Neurobiology Institute, Campus UNAM-Juriquilla, Querétaro 76230, Mexico.
García-Sierra F; Department of Cell Biology, Center of Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Ciudad de Mexico 07360, Mexico.
Gasca-Martínez Y; Development and Neural Regeneration Laboratory, Cell and Molecular Biology Department, CUCBA, University of Guadalajara, Zapopan 45220, Mexico.
Beas-Zárate C; Development and Neural Regeneration Laboratory, Cell and Molecular Biology Department, CUCBA, University of Guadalajara, Zapopan 45220, Mexico.

Pharmaceuticals (Basel) ; 13(12)2020 Nov 26.

Article em En | MEDLINE | ID: mdl-33255969